| (Values in U.S. Thousands) | Sep, 2023 | Jun, 2023 | Mar, 2023 | Sep, 2022 | Jun, 2022 |
| Sales | 183 | 194 | 1,433 | 4,855 | 6,543 |
| Sales Growth | -5.65% | -86.49% | -70.49% | -25.80% | -27.96% |
| Net Income | -3,508 | -1,663 | -2,912 | -3,983 | -6,968 |
| Net Income Growth | -110.96% | +42.89% | +26.89% | +42.84% | -16.57% |
Medivolve Inc (MEDV.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.
Fiscal Year End Date: 12/31